Arena Pharma (ARNA) Announces Cost-Reduction Program; Will Trim U.S. Headcount by 35%

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/3/2026

1. PANW
2. GTLB
3. MDB
4. DELL
5. GOOGL
6. VRTS
7. SPY
8. HPE
9. SNOW
10. USO

Go back to Arena Pharma (ARNA) Announces Cost-Reduction Program; Will Trim U.S. Headcount by 35%

Arena Pharma (ARNA) Announces Additional Patent Issued Covering BELVIQ

October 27, 2015 9:10 AM EDT

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) and Eisai Inc. announced today that the US Patent and Trademark Office granted Arena US Patent No. 9,169,213, entitled "Method of Weight Management," covering BELVIQ® (lorcaserin HCl) for chronic weight management.

"This patent is based on the discovery that... More